539680 — GANGA PHARMACEUTICALS Share Price
0.000.00%
Last trade - 00:00- IN₹65.34m
- IN₹76.19m
- IN₹27.36m
- 10
- 22
- 39
- 10
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.92 | ||
| Price to Tang. Book | 0.92 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.4 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2% | ||
| Return on Equity | 0.87% | ||
| Operating Margin | -5.56% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | 25.86 | 27.36 | n/a | n/a | 5.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -27.14 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ganga Pharmaceuticals Limited is an India-based company. The Company is engaged in the production of ayurvedic medicine. Apart from manufacturing, the Company is also into marketing and distribution of ayurvedic medicines. It offers ayurvedic medicines for acidity, antidandruff, antioxidants, blood purifier and skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and offers herbal cosmetics. Its products include Asuka tablets, Dendroil, Ashwo tablets-tonic for body and mind; Raktaj tablets/syrup for skin disorders; Nirmalaya that relieves constipation; Khadira tablets (80 mg.) that relieves cough; Danta Doshahar Manjan for gum and teeth protective; Holetrica capsule that checks diarrhea and corrects digestion; Karnaraj drops ear drops, Femoherb syrup/tablets, and Mahabhrungraj oil.
Directors
- Anagh Sharma CFO
- Priti Bhaiya CCO
- Bharat Sharma MDR (51)
- Sanjay Kulkarni EDR (61)
- Srijna Sharma EDR (55)
- Sachin Chavan NID (43)
- Chetan Patel NID (38)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- September 11th, 1989
- Public Since
- February 22nd, 2016
- No. of Employees
- 19
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 4,836,500
- Address
- MUMBAI, 401305
- Web
- https://www.ayurvedganga.com/
- Phone
- +91 2506098333
- Contact
- Bharat Sharma
- Auditors
- M/s Banka & Banka
Upcoming Events for 539680
Ganga Pharmaceuticals Ltd Annual Shareholders Meeting
Similar to 539680
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the GANGA PHARMACEUTICALS share price?
As of Today at 20:45 UTC, shares in GANGA PHARMACEUTICALS are trading at IN₹13.51. This share price information is delayed by 15 minutes.
How has the GANGA PHARMACEUTICALS share price performed this year?
Shares in GANGA PHARMACEUTICALS last closed at IN₹13.51 and the price had moved by -42.51% over the past 365 days. In terms of relative price strength the GANGA PHARMACEUTICALS share price has underperformed the S&P BSE 100 Index by -45.84% over the past year.
What are the analyst and broker recommendations for GANGA PHARMACEUTICALS?
There is no consensus recommendation for this security.
Find out moreWhat is the GANGA PHARMACEUTICALS dividend yield?
GANGA PHARMACEUTICALS does not currently pay a dividend.
Does GANGA PHARMACEUTICALS pay a dividend?
GANGA PHARMACEUTICALS does not currently pay a dividend.
When does GANGA PHARMACEUTICALS next pay dividends?
GANGA PHARMACEUTICALS does not currently pay a dividend.
How do I buy GANGA PHARMACEUTICALS shares?
To buy shares in GANGA PHARMACEUTICALS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of GANGA PHARMACEUTICALS?
As of the previous close price of IN₹13.51, shares in GANGA PHARMACEUTICALS had a market capitalisation of IN₹65.34m.
Where are GANGA PHARMACEUTICALS shares listed?
Here are the trading details for GANGA PHARMACEUTICALS:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 539680
What kind of share is GANGA PHARMACEUTICALS?
Based on an overall assessment of its quality, value and momentum GANGA PHARMACEUTICALS is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a GANGA PHARMACEUTICALS share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the GANGA PHARMACEUTICALS share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GANGA PHARMACEUTICALS. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -12.29%.
As of the last closing price of IN₹13.51, shares in GANGA PHARMACEUTICALS were trading +16.68% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the GANGA PHARMACEUTICALS PE Ratio?
The GANGA PHARMACEUTICALS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹13.51.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of GANGA PHARMACEUTICALS?
GANGA PHARMACEUTICALS' management team is headed by:
- Anagh Sharma - CFO
- Priti Bhaiya - CCO
- Bharat Sharma - MDR
- Sanjay Kulkarni - EDR
- Srijna Sharma - EDR
- Sachin Chavan - NID
- Chetan Patel - NID